(HealthDay)—The incidence of juvenile-onset recurrent respiratory papillomatosis (JORRP) in Australia decreased from 2012 to 2016 after implementation of a quadrivalent human papillomavirus (HPV) vaccination program for females aged 12 to 26 years in 2007-2009, according to a study published online Nov. 9 in The Journal of Infectious Diseases.
Trending Articles
More Pages to Explore .....